Integra Therapeutics has developed the FiCAT gene-writing platform to develop cell therapies for autoimmune and oncology diseases and gene therapies for rare diseases. The company recently announced a...
Read more
SpliceBio today announced that it has dosed the first patient in the Phase 1/2 ASTRA study of SB-007, a dual adeno-associated viral (AAV) vector, for the treatment of Stargardt disease. Stargardt dise...
Read more
Las terapias génicas representan uno de los avances más significativos en la medicina moderna. Estas técnicas innovadoras permiten la modificación de los genes dentro de las células de un pacient...
Read more
A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells...
Read more
Puesto en marcha el primer ensayo clínico para pacientes con linfoma refractario, que se basa en un vector no viral desarrollado en España
Read more
A recent study led by the UAB demonstrates the potential of gene therapy to restore motor capacity in an ultra-rare disease, Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC), even when...
Read more
La medicina personalizada o de precisión aprovecha los avances biotecnológicos en diversas disciplinas para mejorar el diagnóstico y adaptar las terapias a la singularidad de cada paciente.
Read more
A CNIC team has developed an innovative gene therapy strategy for arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly inherited condition that particularly affects young ...
Read more
Nature, the world's leading scientific journal, has spotlighted three Barcelona-based biotech startups, Ona Therapeutics, Nuage Therapeutics, and SpliceBio, in a recent article highlighting Spain's bu...
Read more
SparingVision (“the Company”), a clinical-stage genomic medicine company transforming the treatment of retinal disease, announces that it has received FDA agreement for its plan to initiate a Phas...
Read more
La inmunodeficiencia conocida como "deficiencia de adhesión leucocitaria tipo I" (LAD-I) es una grave enfermedad genética que impide a los glóbulos blancos migrar a los tejidos infectados y, aunque...
Read more
An international study led by the Institut de Neurociències at the UAB (INc-UAB) has shown that increasing levels of the Klotho protein in mice extends lifespan and improves both physical and cogniti...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
